投资20亿！瑞生医疗研发中心落户梅溪湖二期

近日，南瑞生医疗科技有限公司眼科器械及生物材料研发产业基地正式落户梅溪湖二期。

Nanruisheng Medical Technology Co. Ltd. will open its ophthalmic device and biomaterial R&D industrial base in Meixi Lake Phase II in Changsha.

该研发产业基地拟投资20亿元，占地面积超2万平方米，主要生产和研发眼科器械原材料、眼科高值耗材、视力保健等专业眼科产品。

Spanning over 20,000 square meters, this 2-billion-yuan R&D facility will primarily produce and develop raw materials for ophthalmic devices, high-value ophthalmic consumables, vision care products, and other specialized ophthalmic products.

未来，瑞生医疗有望能把自主研发的眼科产品，带到国际市场上亮相。

The center looks to bring its eye care products to customers across the globe.